MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Sundry Debtors | ₹848 Cr | ₹576 Cr | ₹388 Cr | ₹331 Cr | ₹531 Cr |
What is the latest Sundry Debtors ratio of MANKIND PHARMA ?
Year | Sundry Debtors |
---|---|
Mar2024 | ₹848 Cr |
Mar2023 | ₹576 Cr |
Mar2022 | ₹388 Cr |
Mar2021 | ₹331 Cr |
Mar2020 | ₹531 Cr |
How is Sundry Debtors of MANKIND PHARMA Trending?
Years | Sundry Debtors | % Change | |
---|---|---|---|
Mar2024 | ₹848 Cr | 47.16 | |
Mar2023 | ₹576 Cr | 48.50 | |
Mar2022 | ₹388 Cr | 17.41 | |
Mar2021 | ₹331 Cr | -37.75 | |
Mar2020 | ₹531 Cr | - |
Compare Sundry Debtors of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹105,592.6 Cr | -0.6% | 7.9% | 6.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹441,910.0 Cr | 5.4% | 3.2% | 20.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,035.0 Cr | 1.9% | 2% | 59.4% | Stock Analytics | |
CIPLA | ₹125,540.0 Cr | 1.7% | 2% | 13.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,894.0 Cr | 2.8% | 2.3% | 22.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,110.0 Cr | 2.1% | -0.9% | -1.5% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | -0.6% |
7.9% |
6.6% |
SENSEX | 1% |
4.3% |
8.9% |
You may also like the below Video Courses